The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Catheter Precision Inc shares valued at $1 were sold by COLOMBATTO MARTIN J on Jan 29 ’25. At $0.40 per share, COLOMBATTO MARTIN J sold 3 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
As published in a research note from Piper Jaffray on August 13, 2019, Catheter Precision Inc [VTAK] has been rated down from an Overweight to a Neutral and the price target has been revised to $1.50 from $9. Analysts at Maxim Group started covering the stock with ‘”a Buy”‘ outlook in a report released in early November.
Analyzing VTAK Stock Performance
During the last five days, there has been a drop of approximately -0.93%. Over the course of the year, Catheter Precision Inc shares have dropped approximately -29.05%. Shares of the company reached a 52-week high of $0.6087 on 01/06/25 and a 52-week low of $0.2400 on 04/07/25. A 50-day SMA is recorded $0.3496, while a 200-day SMA reached $0.7574.
Support And Resistance Levels for Catheter Precision Inc (VTAK)
According to the 24-hour chart, there is a support level at 0.2704, which, if violated, would cause prices to drop to 0.2208. In the upper region, resistance lies at 0.3798. The next price resistance is at 0.4396. RSI (Relative Strength Index) is 45.49 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0084, which suggests the price will decrease in the coming days. Percent R is at 46.67%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
